Lumpy skin disease (LSD)
Current Situation and Project
Activities Proposal to EFSA for
Support
Bulgarian Focal Point
Snezhana Todorova
RAC – BFSA - Bulgaria
Definition
• Lumpy skin disease – LSD is a viral disease in
Large Ruminants with fever,lymphadenopathy,
edema of sub-skin tissues and mucosaes as
well in internal organs.
• It’s connected with appearance of nodules in
skin tissues well seen on a trunk of affected
animals.
• It’s cousin by Pox Virus belonging to the
Genus Capripoxvirus on a Family Poxviridae.
• In Greece LSD was first recorded on 18-th August
in prefecture Evros with 2 EO near to the Turkish
border.
• For a week later were notified 20 secondary
outbreaks alongside the river Evros - north and
become real thereat to Bulgaria.
Spreading of LSD in prefecture Evros
alongside the river Maritza (Evros)
Prognosis for Bulgaria
• More further development of the epidemics will
show us what the measures we can applied if LSDV
will penetrate this year either from Greece, either
form Turkey.
Prognosis for Bulgaria was
estimated worse !!!
• The most risky areas for virus penetration are
the municipalities alongside the rivers in South
Bulgaria – Svilengrad, Lubimetz, Harmanly,
Elhovo, Topolovgrad, Madjarovo, Ivajlovgrad,
Momchilgrad, Djebel, Satovcha, Hadjidimovo,
Petrich.
Preliminary agreements and
correspondence for preparing
draft project with EFSA
1. Discussion between RAC and EFSA units (ALPHA
and AFSCO);
2. Teleconference between RAC – BFSA and EFSA
experts.
Proposal to EFSA for Support
of Balkan Countries Regional Project on LSD
• Draft title:
“Analysis of epidemiological data and
strengthening cooperation between countries
from South East Europe with the support of
EFSA to effectively contain further spread of
Lumpy Skin Disease”
Proposed Draft Activities • Collection and collation of data for epidemiological
analysis regarding LSD situation in Europe.
• Development of a spatio-temporal analysis and
predictive models for disease spreading in different
scenarios;
• Intensive entomological investigations and analysis
for identifying competent vectors, spreading LSDV in
the Balkan region countries;
• Determining seasonal dynamics and daily activities of
the identified competent vectors. Harmonization of a
vector collecting protocols and methodology and
development of standard operating procedures
(SOPs) for different vector types;
• Analysis of the applied disease prevention and control strategies and measures and identifying of the vulnerabilities of the animal health systems in the project countries;
• Analysis of the consequences in different scenarios with and without vaccination and exit strategies (vaccination to live and vaccination for slaughtering).
• Harmonize the strategy for prevention and control of LSD in the affected countries in the Region, based on the results from the efficacy of vaccinations. To assess the immune potency of the vaccine used and to optimize vaccination schemes in the field conditions;
• Carry out intensive PCR analysis for detection LSDV genome segments in captured blood suckling vectors (mosquitoes, flies, ticks);
Preliminary agreements and correspondence
EFSA and the European Commission are arranging the
Workshop “Strengthening regional cooperation in
South East Europe and Middle East for prevention
and control of Lumpy Skin Disease” to occur on 11-
12 May 2016 in EC premises, Brussels, Belgium.
Preliminary agreements and correspondence
The aim of the workshop is to increase the awareness on the epidemiological situation of LSD and to improve cooperation at regional level for LSD surveillance, prevention and control by:
- establishing synergies;
- identifying specific needs and possible instruments to satisfy them;
- sharing of best practices;
- preparing a list of shared recommendations valid for LSD and other transboundary diseases.
Preliminary agreements and correspondence
The expected outputs of this workshop will be:
• To update and exchange information on LSD
epidemiology in the different regions
concerned;
• to highlight the country specific needs in order
to increase the preparedness for LSD control;
• to share best practices;
• to promote coordinated actions at regional
level ensuring coherence and synergies;
• to encourage cooperation;
• to optimise use of resources;
• to prepare a list of shared recommendations for
the LSD prevention and control, with an
indication of the recommendations to be
considered valid for the prevention and control
of other transboundary diseases, in order to
allow for a systematic approach. This will be
part of a report that will be shared and
endorsed by the participants;
• to identify the most suitable instruments and/or
funding bodies in order to satisfy the
identified needs.
Thank you for the attention!